Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-077002
Filing Date
2021-06-04
Accepted
2021-06-04 16:07:18
Documents
1
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2118520-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2118520-1_4seq1.xml 4 7829
  Complete submission text file 0001104659-21-077002.txt   9288
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REDMILE GROUP, LLC ONE LETTERMAN DR., BLDG. D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Lee Michael Stewart (Reporting) CIK: 0001748010 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36076 | Film No.: 21996503